Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
HERS follow-up suggests no CHD benefit and higher VTE risk with HRT; leaves open questions on long-term use in high-risk women.
Grady et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: